theophylline

1
Reactions 627 - 16 Nov 1996 Theophylline Adverse effects in an elderly patient: case report The following report describes theophylline toxicity that was initially diagnosed as peptic ulcer disease, in an 82-year-old man. He had been successfully treated for a duodenal ulcer 8 years earlier. The man was hospitalised with nausea, vomiting and dyspepsia of several weeks duration; he had a history of bodyweight loss over the past year. His amylase levels were slightly elevated. One year earlier, he had started treatment with sustained release theophylline 600 mg/day for chronic obstructive pulmonary disease. Initially, the man was treated with cimetidine. However, the nausea and vomiting persisted. His treatment was changed to ranitidine, but this did not relieve his symptoms either. His symptoms then worsened and treatment with famotidine was also unsuccessful. The man was hospitalised again and, on admission, physical findings were normal apart from tachycardia. His serum amylase level had increased further and his creatine kinase-MB level was elevated. His theophylline level was 35 µg/ml (therapeutic range 1–20). Theophylline and famotidine were discontinued. By the fourth hospital day, his symptoms had resolved. His serum amylase and creatine kinase-MB levels normalised. At 2 months’ follow-up, he had not experienced any further gastrointestinal disorders or tachycardia. Author comment: This patient was misdiagnosed as having peptic ulcer disease because of his past medical history and gastrointestinal disorders. ‘All of the histamine H2-receptor antagonists used in the treatment of this patient could have theoretically inhibited theophylline metabolism and aggravated theophylline toxicity.’ Theophylline should be used very cautiously in elderly patients. Alterman P, et al. Histamine H2-receptor antagonists and chronic theophylline toxicity. American Family Physician 54: 1473 & 1477, Oct 1996 - Israel 800476234 1 Reactions 16 Nov 1996 No. 627 0114-9954/10/0627-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: dohanh

Post on 19-Mar-2017

215 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Theophylline

Reactions 627 - 16 Nov 1996

Theophylline

Adverse effects in an elderly patient: case reportThe following report describes theophylline toxicity that was

initially diagnosed as peptic ulcer disease, in an 82-year-oldman. He had been successfully treated for a duodenal ulcer 8years earlier.

The man was hospitalised with nausea, vomiting anddyspepsia of several weeks duration; he had a history ofbodyweight loss over the past year. His amylase levels wereslightly elevated. One year earlier, he had started treatmentwith sustained release theophylline 600 mg/day for chronicobstructive pulmonary disease.

Initially, the man was treated with cimetidine. However, thenausea and vomiting persisted. His treatment was changed toranitidine, but this did not relieve his symptoms either. Hissymptoms then worsened and treatment with famotidine wasalso unsuccessful.

The man was hospitalised again and, on admission, physicalfindings were normal apart from tachycardia. His serumamylase level had increased further and his creatine kinase-MBlevel was elevated. His theophylline level was 35 µg/ml(therapeutic range 1–20). Theophylline and famotidine werediscontinued. By the fourth hospital day, his symptoms hadresolved. His serum amylase and creatine kinase-MB levelsnormalised. At 2 months’ follow-up, he had not experiencedany further gastrointestinal disorders or tachycardia.

Author comment: This patient was misdiagnosed as havingpeptic ulcer disease because of his past medical history andgastrointestinal disorders. ‘All of the histamine H2-receptorantagonists used in the treatment of this patient could havetheoretically inhibited theophylline metabolism and aggravatedtheophylline toxicity.’ Theophylline should be used verycautiously in elderly patients.Alterman P, et al. Histamine H2-receptor antagonists and chronic theophyllinetoxicity. American Family Physician 54: 1473 & 1477, Oct 1996 -Israel 800476234

1

Reactions 16 Nov 1996 No. 6270114-9954/10/0627-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved